These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 16807451)

  • 1. Gemcitabine and taxanes in metastatic breast cancer.
    Amadori D; Cecconetto L
    Ann Oncol; 2006 May; 17 Suppl 5():v173-6. PubMed ID: 16807451
    [No Abstract]   [Full Text] [Related]  

  • 2. Gemcitabine combination chemotherapy in metastatic breast cancer: phase II experience.
    O'Shaughnessy J
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):15-21. PubMed ID: 14768400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gemcitabine combined with docetaxel in metastatic breast cancer.
    Fumoleau P
    Semin Oncol; 2003 Apr; 30(2 Suppl 3):15-8. PubMed ID: 12722020
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New: gemzar plus taxan in metastatic breast carcinoma. Optimal combination].
    Krankenpfl J; 2003; 41(7-9):171. PubMed ID: 14705529
    [No Abstract]   [Full Text] [Related]  

  • 5. [Metastatic breast cancer: new chemotherapy regimens with taxanes].
    Lopez M
    Clin Ter; 2005; 156(6):311-5. PubMed ID: 16463568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gemcitabine and taxanes as a new standard of care in breast cancer.
    Yardley DA
    Clin Breast Cancer; 2004 Jan; 4 Suppl 3():S107-12. PubMed ID: 14754467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early change in tumour size predicts overall survival in patients with first-line metastatic breast cancer.
    Tate SC; Andre V; Enas N; Ribba B; Gueorguieva I
    Eur J Cancer; 2016 Oct; 66():95-103. PubMed ID: 27544929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma].
    Longo F; Mansueto G
    Tumori; 2004; 90(5):1-8. PubMed ID: 15656346
    [No Abstract]   [Full Text] [Related]  

  • 9. Salvage chemotherapy in anthracycline-pretreated metastatic breast cancer patients with docetaxel and gemcitabine: a multicenter phase II trial. Greek Breast Cancer Cooperative Group.
    Mavroudis D; Malamos N; Alexopoulos A; Kourousis C; Agelaki S; Sarra E; Potamianou A; Kosmas C; Rigatos G; Giannakakis T; Kalbakis K; Apostolaki F; Vlachonicolis J; Kakolyris S; Samonis G; Georgoulias V
    Ann Oncol; 1999 Feb; 10(2):211-5. PubMed ID: 10093691
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Gemcitabine, anthracycline, and taxane combinations for advanced breast cancer.
    Zielinski CC
    Oncology (Williston Park); 2003 Dec; 17(12 Suppl 14):36-40. PubMed ID: 14768404
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Taxanes and gemcitabine doublets in the management of HER-2 negative metastatic breast cancer: towards optimization of association and schedule.
    Metro G; Fabi A; Russillo M; Papaldo P; De Laurentiis M; Ferretti G; Pellegrini D; Nuzzo C; Graziano V; Vici P; Introna M; Felici A; Cognetti F; Carlini P
    Anticancer Res; 2008; 28(2B):1245-58. PubMed ID: 18505062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overview of gemcitabine activity in advanced breast cancer.
    Smith IE
    Semin Oncol; 2006 Jun; 33(3 Suppl 9):S19-23. PubMed ID: 16797378
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Updates on gemcitabine on metastatic breast cancer].
    Gligorov J; Selle F; Khalil A; Abbas F; Namer M; Lotz JP
    Bull Cancer; 2007; 94 Spec No Actualites():S90-4. PubMed ID: 17845977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Docetaxel/gemcitabine: salvage chemotherapy in anthracycline-pretreated patients with advanced breast cancer.
    Georgoulias VA
    Oncology (Williston Park); 2001 Feb; 15(2 Suppl 3):18-24. PubMed ID: 11252884
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gemcitabine and docetaxel in metastatic breast cancer.
    Seidman AD
    Oncology (Williston Park); 2004 Dec; 18(14 Suppl 12):13-6. PubMed ID: 15685820
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monthly docetaxel and weekly gemcitabine in metastatic breast cancer: a phase II trial.
    Laufman LR; Spiridonidis CH; Pritchard J; Roach R; Zangmeister J; Larrimer N; Moore T; Segal M; Jones J; Patel T; Gutterman L; Carman L; Colborn D; Kuebler JP
    Ann Oncol; 2001 Sep; 12(9):1259-64. PubMed ID: 11697837
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Weekly docetaxel with or without gemcitabine as second-line chemotherapy in paclitaxel-pretreated patients with metastatic breast cancer: a randomized phase II study conducted by the Hellenic Co-Operative Oncology Group.
    Papadimitriou CA; Kalofonos H; Zagouri F; Papakostas P; Bozas G; Makatsoris T; Dimopoulos MA; Fountzilas G
    Oncology; 2009; 77(3-4):212-6. PubMed ID: 19729979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of gemcitabine in metastatic breast cancer patients: a short review.
    Silvestris N; Cinieri S; La Torre I; Pezzella G; Numico G; Orlando L; Lorusso V
    Breast; 2008 Jun; 17(3):220-6. PubMed ID: 18037292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomised phase 3 open-label trial of first-line treatment with gemcitabine in association with docetaxel or paclitaxel in women with metastatic breast cancer: a comparison of different schedules and treatments.
    Del Mastro L; Fabi A; Mansutti M; De Laurentiis M; Durando A; Merlo DF; Bruzzi P; La Torre I; Ceccarelli M; Kazeem G; Marchi P; Boy D; Venturini M; De Placido S; Cognetti F
    BMC Cancer; 2013 Mar; 13():164. PubMed ID: 23537313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neoadjuvant gemcitabine therapy for breast cancer.
    Sánchez-Rovira P; Jaén A; Dueñas R; Porras I; Martínez E; Medina B; Mohedano N; Fernández M; Lozano A
    Clin Breast Cancer; 2002 May; 3 Suppl 1():39-44. PubMed ID: 12057045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.